Journal of Organic Chemistry 2004-05-28

Selective iron-catalyzed cross-coupling reactions of grignard reagents with enol triflates, acid chlorides, and dichloroarenes.

Bodo Scheiper, Melanie Bonnekessel, Helga Krause, Alois Fürstner

Index: J. Org. Chem. 69 , 3943-3949, (2004)

Full Text: HTML

Abstract

Cheap, readily available, air stable, nontoxic, and environmentally benign iron salts such as Fe(acac)(3) are excellent precatalysts for the cross-coupling of Grignard reagents with alkenyl triflates and acid chlorides. Moreover, it is shown that dichloroarene and -heteroarene derivatives as the substrates can be selectively monoalkylated by this method. All cross-coupling reactions proceed very rapidly under notably mild conditions and turned out to be compatible with a variety of functional groups in both reaction partners. A detailed analysis of the preparative results suggests that iron-catalyzed C-C bond formations can occur via different pathways. Thus, it is likely that reactions of methylmagnesium halides involve iron-ate complexes as the active components, whereas reactions of Grignard reagents with two or more carbon atoms are effected by highly reduced iron-clusters of the formal composition [Fe(MgX)(2)](n) generated in situ. Control experiments using the ate-complex [Me(4)Fe]Li(2) corroborate this interpretation.


Related Compounds

  • 2,4-Dichloropyrimi...

Related Articles:

Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.

2007-07-26

[J. Med. Chem. 50 , 3497, (2007)]

One-pot Double Suzuki Couplings of Dichloropyrimidines.

2012-02-01

[Synthesis 2010(16) , 2721-2724, (2010)]

An efficient route to 4-aryl-5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine.

2006-01-19

[Org. Lett. 8(2) , 269-72, (2006)]

Chemistry-based risk assessment for skin sensitization: quantitative mechanistic modeling for the S(N)Ar domain.

2011-07-18

[Chem. Res. Toxicol. 24(7) , 1003-11, (2011)]

Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.

2007-06-15

[Bioorg. Med. Chem. Lett. 17 , 3463, (2007)]

More Articles...